Members-Only Article

Keep An Eye On This

Vials used by pharmacists to prepare syringes used on the first day of a first-stage safety study clinical trial of the potential vaccine for COVID-19, the disease caused by the new coronavirus, rest on a lab table at the Kaiser Permanente Washington Health Research Institute in Seattle on Monday, March 16, 2020. (AP Photo/Ted S. Warren) — FILE - This March 16, 2020 file photo shows vials used by pharmacists to prepare syringes used on the first day of a first-stage safety study clinical trial of the potential vaccine for COVID-19, the disease caused b... FILE - This March 16, 2020 file photo shows vials used by pharmacists to prepare syringes used on the first day of a first-stage safety study clinical trial of the potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. The world's biggest COVID-19 vaccine test got underway Monday, July 27 with the first of 30,000 planned volunteers. The experimental vaccine is made by the National Institutes of Health and Moderna Inc., and it's one of several candidates in the final stretch of the global vaccine race. (AP Photo/Ted S. Warren, File) MORE LESS

September 4, 2020 3:57 p.m.

We’re keyed in on how President Trump is pushing to prioritize his own re-election above public health by rushing out a COVID vaccine before it’s ready. The story has a lot of moving parts, but we’re keeping a close eye on a scheduled meeting in late October.

This is a members-only article

Small Team. Big Results.

We’re proud of what our small newsroom has accomplished and it’s not hyperbole when we say that without our members, none of this would be possible.

Become a TPM Member

Free memberships available for students and those experiencing financial hardship.

Already a member? SIGN IN